fbpx

Peripheral Nerve Sheath Cancer

Malignant Peripheral Nerve Sheath Tumor

Female, 41 years

Patient Internal ID: 75735747

ICD-10 code

C47.0 Malignant Neoplasm: Peripheral Nerves of Head, Face, and Neck

Diagnosis (Incl. Metastases/Stage) and Year

December 2019
Malignant Peripheral Nerve Sheath Tumor pT3 N0M0, LVI (1), Ki67 – 30%. G3, No Lymph Node Metastases.

Previous Treatment

Surgery, Radiation Therapy.

Prognosis and Survival Expectation

The pooled data of 22 studies suggests that Malignant Peripheral Nerve Sheath Tumor 5-year overall survival rate was around 49%.

Treatment Provided

Autologous DCV (8 doses) and CIK (4 doses) over a period of 11 months. Additionally, the patient received Xenogeneic Preventive and Therapeutic Anti-Cancer Vaccine (PTAC) (10 vaccines) as well as Umbilical Cord Blood Derived NK cells (4 doses).

Patient Survival/Condition and Year
Date of Review: 01/11/2023

The patient has survived for 47 months so far, has no signs of disease and has regular check-ups with his oncologist. It can be concluded that the addition of Immunotherapy, alongside Surgery and Radiation Therapy, caused noticeable disease regression and stabilisation.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.